Bixiye
BCBSMN_PharmProgPolicyNotifctn_2021-0101v4.pdf
Natiijooyinka Raadinta
Soo bandhiga 1301 - 1310 ee natiijooyinka 4162
Bixiye
QP64R2-20 Update: Medical Drug Update for Viltolarsen (Viltepso)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 11, 2020
Bixiye
QP107-20 Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective January 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: Nov 11, 2020
Bixiye
QP108-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations
Taariikhda uu dhaqangalayo Barnaamijka: Nov 11, 2020
Bixiye
QP109-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Antiemetic Agents
Taariikhda uu dhaqangalayo Barnaamijka: Nov 11, 2020
Bixiye
P50R2-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment and Post-Acute Care Services for Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P49R1-20 CERiS Review of High Dollar Claims
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P78-20 Reminder: New Prior Authorization Timeframes Required by Legislation
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020